These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 22699931

  • 21. Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation.
    Ichikawa H, Aggarwal BB.
    Clin Cancer Res; 2006 Jan 15; 12(2):662-8. PubMed ID: 16428513
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.
    Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B.
    J Cancer Res Clin Oncol; 2012 May 15; 138(5):785-97. PubMed ID: 22270965
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway.
    Lou C, Lu H, Ma Z, Liu C, Zhang Y.
    Biomed Pharmacother; 2019 Jan 15; 109():563-572. PubMed ID: 30399592
    [Abstract] [Full Text] [Related]

  • 26. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo.
    Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B.
    Cancer Lett; 2010 Jul 01; 293(1):99-108. PubMed ID: 20137856
    [Abstract] [Full Text] [Related]

  • 27. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
    Ali S, Banerjee S, Schaffert JM, El-Rayes BF, Philip PA, Sarkar FH.
    J Cell Biochem; 2010 May 01; 110(1):171-81. PubMed ID: 20213764
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.
    Guo HC, Bu HQ, Luo J, Wei WT, Liu DL, Chen H, Tong HF, Wang ZH, Wu HY, Li HH, Zuo MM, Li W, Lin SZ.
    Int J Oncol; 2012 Jun 01; 40(6):1849-57. PubMed ID: 22378302
    [Abstract] [Full Text] [Related]

  • 30. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
    Liu J, Ma J, Wu Z, Li W, Zhang D, Han L, Wang F, Reindl KM, Wu E, Ma Q.
    BMC Cancer; 2014 Sep 20; 14():686. PubMed ID: 25240403
    [Abstract] [Full Text] [Related]

  • 31. Phenoxodiol enhances the antitumor activity of gemcitabine in gallbladder cancer through suppressing Akt/mTOR pathway.
    Li Y, Huang X, Huang Z, Feng J.
    Cell Biochem Biophys; 2014 Nov 20; 70(2):1337-42. PubMed ID: 24902539
    [Abstract] [Full Text] [Related]

  • 32. Coix seed emulsion synergistically enhances the antitumor activity of gemcitabine in pancreatic cancer through abrogation of NF-κB signaling.
    Qian Y, Yang B, Xiong Y, Gu M.
    Oncol Rep; 2016 Sep 20; 36(3):1517-25. PubMed ID: 27459907
    [Abstract] [Full Text] [Related]

  • 33. Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells.
    Kim ES, Hong SY, Lee HK, Kim SW, An MJ, Kim TI, Lee KR, Kim WH, Cheon JH.
    Oncol Rep; 2008 Dec 20; 20(6):1321-7. PubMed ID: 19020709
    [Abstract] [Full Text] [Related]

  • 34. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
    Ju HQ, Li H, Tian T, Lu YX, Bai L, Chen LZ, Sheng H, Mo HY, Zeng JB, Deng W, Chiao PJ, Xu RH.
    J Pineal Res; 2016 Jan 20; 60(1):27-38. PubMed ID: 26445000
    [Abstract] [Full Text] [Related]

  • 35. Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer.
    Husain K, Francois RA, Yamauchi T, Perez M, Sebti SM, Malafa MP.
    Mol Cancer Ther; 2011 Dec 20; 10(12):2363-72. PubMed ID: 21971120
    [Abstract] [Full Text] [Related]

  • 36. Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice.
    Mita Y, Ajiki T, Kamigaki T, Okazaki T, Hori H, Horiuchi H, Hirata K, Fujita T, Fujimori T, Kuroda Y.
    Ann Surg Oncol; 2007 Apr 20; 14(4):1374-80. PubMed ID: 17235714
    [Abstract] [Full Text] [Related]

  • 37. Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.
    Pignochino Y, Sarotto I, Peraldo-Neia C, Penachioni JY, Cavalloni G, Migliardi G, Casorzo L, Chiorino G, Risio M, Bardelli A, Aglietta M, Leone F.
    BMC Cancer; 2010 Nov 18; 10():631. PubMed ID: 21087480
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice.
    Fujiwara Y, Shiba H, Iwase R, Haruki K, Furukawa K, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Am Coll Surg; 2013 Feb 18; 216(2):320-32.e3. PubMed ID: 23219147
    [Abstract] [Full Text] [Related]

  • 39. New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer.
    Horiuchi T, Uwagawa T, Shirai Y, Saito N, Iwase R, Haruki K, Shiba H, Ohashi T, Yanaga K.
    J Surg Res; 2016 Nov 18; 206(1):1-8. PubMed ID: 27916347
    [Abstract] [Full Text] [Related]

  • 40. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
    Manu KA, Shanmugam MK, Ramachandran L, Li F, Fong CW, Kumar AP, Tan P, Sethi G.
    Clin Cancer Res; 2012 Apr 15; 18(8):2220-9. PubMed ID: 22351692
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.